Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/16664
Full metadata record
DC FieldValueLanguage
dc.contributor.authorOgden, Kevin K-
dc.contributor.authorChen, Wenjuan-
dc.contributor.authorSwanger, Sharon A-
dc.contributor.authorMcDaniel, Miranda J-
dc.contributor.authorFan, Linlin Z-
dc.contributor.authorHu, Chun-
dc.contributor.authorTankovic, Anel-
dc.contributor.authorKusumoto, Hirofumi-
dc.contributor.authorKosobucki, Gabrielle J-
dc.contributor.authorSchulien, Anthony J-
dc.contributor.authorSu, Zhuocheng-
dc.contributor.authorPecha, Joseph-
dc.contributor.authorBhattacharya, Subhrajit-
dc.contributor.authorPetrovski, Slavé-
dc.contributor.authorCohen, Adam E-
dc.contributor.authorAizenman, Elias-
dc.contributor.authorTraynelis, Stephen F-
dc.contributor.authorHongjie, Yuan-
dc.date2017-01-17-
dc.date.accessioned2017-06-01T05:56:37Z-
dc.date.available2017-06-01T05:56:37Z-
dc.date.issued2017-01-17-
dc.identifier.citationPLoS Genetics 2017; 13(1): e1006536en_US
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/16664-
dc.description.abstractN-methyl-D-aspartate receptors (NMDARs), ligand-gated ionotropic glutamate receptors, play key roles in normal brain development and various neurological disorders. Here we use standing variation data from the human population to assess which protein domains within NMDAR GluN1, GluN2A and GluN2B subunits show the strongest signal for being depleted of missense variants. We find that this includes the GluN2 pre-M1 helix and linker between the agonist-binding domain (ABD) and first transmembrane domain (M1). We then evaluate the functional changes of multiple missense mutations in the NMDAR pre-M1 helix found in children with epilepsy and developmental delay. We find mutant GluN1/GluN2A receptors exhibit prolonged glutamate response time course for channels containing 1 or 2 GluN2A-P552R subunits, and a slow rise time only for receptors with 2 mutant subunits, suggesting rearrangement of one GluN2A pre-M1 helix is sufficient for rapid activation. GluN2A-P552R and analogous mutations in other GluN subunits increased the agonist potency and slowed response time course, suggesting a functionally conserved role for this residue. Although there is no detectable change in surface expression or open probability for GluN2A-P552R, the prolonged response time course for receptors that contained GluN2A-P552R increased charge transfer for synaptic-like activation, which should promote excitotoxic damage. Transfection of cultured neurons with GluN2A-P552R prolonged EPSPs, and triggered pronounced dendritic swelling in addition to excitotoxicity, which were both attenuated by memantine. These data implicate the pre-M1 region in gating, provide insight into how different subunits contribute to gating, and suggest that mutations in the pre-M1 helix can compromise neuronal health. Evaluation of FDA-approved NMDAR inhibitors on the mutant NMDAR-mediated current response and neuronal damage provides a potential clinical path to treat individuals harboring similar mutations in NMDARs.en_US
dc.subjectIon Channel Gatingen_US
dc.subjectMutation, Missenseen_US
dc.subjectNerve Tissue Proteinsen_US
dc.subjectNervous System Diseasesen_US
dc.subjectReceptors, N-Methyl-D-Aspartateen_US
dc.titleMolecular mechanism of disease-associated mutations in the pre-M1 helix of NMDA receptors and potential rescue pharmacologyen_US
dc.typeJournal Articleen_US
dc.identifier.journaltitlePLoS Geneticsen_US
dc.identifier.affiliationDepartment of Pharmacology, Emory University School of Medicine, Atlanta, GA, USAen_US
dc.identifier.affiliationDepartment of Neurology, Xiangya Hospital, Central South University, Changsha, Chinaen_US
dc.identifier.affiliationDepartment of Chemistry and Chemical Biology, Howard Hughes Medical Institute, Harvard University, Cambridge, MA, USAen_US
dc.identifier.affiliationDepartment of Neurobiology, University of Pittsburgh School of Medicine and Pittsburgh Institute for Neurodegenerative Diseases, Pittsburgh, PA, USAen_US
dc.identifier.affiliationDepartment of Medicine, The University of Melbourne, Austin Health and Royal Melbourne Hospital, Melbourne, Victoria, Australiaen_US
dc.identifier.affiliationCenter for Functional Evaluation of Rare Variants (CFERV), Emory University School of Medicine, Rollins Research Center, Atlanta, GA, USAen_US
dc.identifier.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/28095420en_US
dc.identifier.doi10.1371/journal.pgen.1006536en_US
dc.type.contentTexten_US
dc.type.austinJournal Articleen_US
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.openairetypeJournal Article-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

4
checked on Mar 28, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.